In a dental clinic in São Paulo, a patient stares at a TV screen, trying to understand the faint shadows and lines of their panoramic radiograph. The dentist, using a platform called Di, clicks a button. The image transforms. Red overlays highlight areas of pathology, blue marks previous work, and a structured report appears beside it, translating the clinical findings into a visual roadmap for treatment. The company’s bet is that AI-powered analysis can do more than just flag cavities; it can become a communication tool that builds trust and, ultimately, drives case acceptance for dentists.
Founded in 2022, DIO operates in a space crowded with well-funded AI radiology readers like Overjet and Pearl. Its differentiation lies not in claiming superior detection algorithms, but in focusing the output on the dentist-patient conversation. The software is built for the private practice, where the business case hinges on converting consultations into procedures. By generating a color-coded, editable visual plan that can be shared via WhatsApp or displayed chairside, DIO aims to insert itself directly into the clinical workflow where financial and clinical decisions meet.
The wedge of visual communication
For DIO, the product moat is the treatment plan, not the detection. While competitors often emphasize regulatory-grade accuracy for insurers or large dental service organizations (DSOs), DIO’s platform appears tailored for the independent practitioner. The workflow is straightforward: upload a radiograph, wait for AI processing, review the automated findings, edit notes, and export a report. It promises to save time on manual annotation and to provide a tangible artifact that helps patients understand complex dental work.
Credentials from clinical partnerships
The startup’s early credibility stems from its academic and clinical affiliations. DIO was created in partnership with CETAO, a prominent dental education institute, and HOC, a leading dental hospital in São Paulo. This collaboration provides access to clinical expertise and potentially to annotated datasets. The founding team includes alumni from the University of São Paulo (USP), further anchoring the company in Brazil’s medical ecosystem.
Traction in a seed-stage landscape
DIO’s disclosed funding totals approximately R$4 million (around $760,000) in a seed round from investors including Triaxis Capital, Crescera Capital, and Renato Velloso. The company’s public go-to-market materials consistently target individual dentists and clinics, operating on what appears to be a subscription or usage-based SaaS model.
| Competitor | Primary Geography | Key Focus |
|---|---|---|
| DIO Inteligência Odontológica | Brazil / Latin America | Visual treatment plans & patient communication for private practices |
| Overjet | United States | AI-powered clinical insights & insurance audit support for DSOs & insurers |
| Pearl AI | United States / Global | Regulatory-grade AI for detection, focusing on radiograph quality & pathology |
| VideaHealth | United States | AI analysis for dental radiographs, often integrated with practice management software |
Where the path gets narrow
- Clinical validation. The most significant hurdle is proving clinical utility. Detection accuracy claims, without independent study or regulatory clearance, remain marketing points.
- Commercial scalability. Serving fragmented, individual dental practices is a classic distribution challenge. The sales motion is high-touch and unit economics are tough at low price points.
- Competitive encroachment. While global players like Overjet are focused on large DSOs and insurers today, a successful model in private practice communication could attract them downstream or inspire local clones.
The next twelve months
The coming year will be defining. Key milestones will likely include publishing initial user or outcomes data from its hospital partner, HOC. Another logical step would be a formal regulatory submission to ANVISA, Brazil’s health authority. On the commercial front, watch for partnerships with dental practice management software providers in Brazil, a move that would drastically improve distribution. Another seed extension or a Series A round will be necessary to fund these ambitions.